PRICE T ROWE ASSOCIATES INC /MD/ - AERPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AERPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$429,000
+31.2%
253,7000.0%0.00%
Q1 2021$327,000253,7000.00%
Other shareholders
AERPIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 5,621,835$7,252,0003.21%
Parkman Healthcare Partners LLC 1,001,189$1,292,0000.30%
ABG Innovation Capital Partners III GP Ltd 400,000$516,0000.25%
Opaleye Management Inc. 1,000,000$1,290,0000.19%
EcoR1 Capital, LLC 2,072,782$2,674,0000.12%
Ikarian Capital, LLC 2,651,093$3,420,0000.12%
Scion Asset Management 1,000,000$1,290,0000.10%
Orbimed Advisors 5,193,946$6,700,0000.06%
Keudell/Morrison Wealth Management 30,694$40,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 302,949$391,0000.02%
View complete list of AERPIO PHARMACEUTICALS INC shareholders